4,423
Views
3
CrossRef citations to date
0
Altmetric
Pharmacoeconomic Evaluation

Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed?

ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 923-935 | Received 30 Sep 2020, Accepted 06 Jan 2021, Published online: 13 Jan 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.